
Hepatology Communications: Official open access journal of the AASLD (@AASLDtweets)| Co-editors in Chief: @ebtapper and Dr. Wong| #SoMe Editor: @jlouissaint89
Alexandria, VA
Joined April 2019
- Tweets1.9K
- Following260
- Followers8K
- Likes1.4K
📑 Seladelpar in patients with #PBC and compensated #cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies‼️
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
📑#MetALD is emerging as a major 🌎 liver disease phenotype‼️
⭐️10-20% of people with hepatic steatosis meet MetALD criteria❕
⚠️Metabolic dysfunction ➕ alcohol 🍻➡️ increased risks of fibrosis progression, cirrhosis, & HCC❕
#OpenAccess
journals.lww.com/hepcomm/ful…
Hepatology Communications retweeted
Pleased to share our study on gaps in awareness of metabolic liver disease. Among 1,000 US adults with elevated metabolic risk, 60% recognized “fatty liver disease,” but only 13% were familiar with #MASLD and 12% with #MASH. Just 13% reported concern about liver disease. These findings reinforce why liver health needs to be part of our everyday conversations with patients about obesity and diabetes.
ovid.com/jnls/hepcomm/fullte…
📑 L-Taurine for #Fatigue in Decompensated Cirrhosis⁉️
❎ Negative trial overall
⭐️ BUT, patients without anemia🩸 had a large ⬇️ in fatigue 😴, while those with anemia did not❕
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
📑 Low serum pseudocholinesterase levels are associated with mortality in patients with #HCC‼️
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
Hepatology Communications retweeted
Have you signed up for #HepMadness2026 yet? 🏆
16 hepatology themes go head-to-head!
A great learning opportunity with recent articles handpicked from @LTxJournal & @HepCommJournal, summarized by team @LiverFellow.
Open to ALL! Make your picks by Oct 31! 🔥
Sign up & FAQs here 🔗 aasld.org/liver-fellow-n…
🥇 to be announced at #TLM2026
@AASLDtweets @AASLDFoundation @AASLDPresident @ebtapper @jlouissaint89 @WAleyadeh @SarahKhan9894
Replying to @LiverFellow
5/6 Here’s the full bracket. 👇
Tell us your champion pick right now. Bold calls only. Upsets encouraged.
Hepatology Communications retweeted
Huge review on patient and caregiver reported outcome in ascites from Dr Sumita Verma’s group journals.lww.com/hepcomm/ful…
Open access in @HepCommJournal
Everything from pooled estimates to impact of interventions
Hepatology Communications retweeted
5/5 Does this theme make your next round—or go all the way? 🏆
Submit your bracket by Oct 31:
tourneytopia.com/aasld/hepma…
@LTxJournal @HepCommJournal @aasldtweets #HepMadness2026
Hepatology Communications retweeted
5/5 Is this your championship pick? 🏆
Explore the evidence and submit your bracket by Oct 31:
tourneytopia.com/aasld/hepma…
@LTxJournal @HepCommJournal @aasldtweets #HepMadness2026
📑 Group-based #telehealth 💻behavioral interventions for chronic liver disease‼️
A 14-week group telehealth intervention achieved 84% retention & 91% session attendance❕
⭐️Improvement trends in stress, coping, relaxation 🧘, & sleep hygiene 😴
journals.lww.com/hepcomm/ful…
Hepatology Communications retweeted
1/6 🚨 THE BRACKET IS LIVE 🚨
HepMadness 2026 starts NOW.
16 themes. 4 rounds. 1 champion 🏆
The best hepatology and transplant science of the year, going head to head. Who survives?
#HepMadness2026
aasld.org/liver-fellow-netwo…
📑 Autoimmune liver diseases in Latin America 🌎: Current landscape and challenges‼️
#OpenAccess #LiverX #PBC #AIH
journals.lww.com/hepcomm/ful…
📑 Molnupiravir is effective against hepatitis E virus infection in an animal model‼️🦠
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
Hepatology Communications retweeted
🎉 A historic milestone for AASLD journals!
@HEP_Journal has achieved its highest-ever #ImpactFactor of 21.3, reinforcing its position as a global leader in liver research and scientific discovery.
The milestones don't stop there! @HepCommJournal also reached a record-high Impact Factor of 6.2.
These achievements reflect the exceptional contributions of our authors, reviewers, and editorial teams and AASLD's continued commitment to advancing liver science and improving patient care worldwide.
Read the full announcement: bit.ly/4jndxRJ
📑 Integrating behavioral health into hepatology improves #AUD care‼️🍺
⬆️ Any AUD treatment: 80% vs 28%
⬆️ Psychotherapy: 76% vs 24%
⬆️ Pharmacotherapy: 41% vs 12% 💊
#OpenAccess #LiverX
@ponnivp
journals.lww.com/hepcomm/ful…
Hepatology Communications retweeted
🔥 HOT TOPIC
📘 @HepCommJournal
Nearly 1 in 5 youth with biopsy-confirmed #MASLD began drinking during adolescence or early adulthood.
In the largest longitudinal study of its kind, researchers followed more than 1,100 youth and found that alcohol use was associated with faster increases in liver enzymes, reinforcing the importance of routine alcohol screening and developmentally tailored counseling in pediatric MASLD care.
Read the article: bit.ly/4rPDaN0
📑 Better pathways ➡️ better detection 🔎of advanced #MASLD‼️
⭐️A 2-step FIB4/MAF4/NFS ➡️ VCTE pathway ⬆️ correct hepatology referral rates❕
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
📑 "Lean" doesn't mean mild #MASLD‼️
💉 Histologic severity was identical in normal-weight and overweight adults:
⭐️ 26% had advanced fibrosis
⭐️ 8% had #cirrhosis
Severity ⬆️ once BMI > 30
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
📑 Who is most likely to fall in #cirrhosis⁉️
Strongest risks:
🚨Prior Fall
🚨Frailty
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
Hepatology Communications retweeted
📑 Therapeutic restoration of miR-126-3p as a multi-targeted strategy to modulate the liver tumor microenvironment❕
#LiverTwitter #OpenAccess
journals.lww.com/hepcomm/ful…


























